Science policy news weekly roundup: August 26, 2016 ?>

Science policy news weekly roundup: August 26, 2016


The ASBMB’s Public Affairs office encourages all readers of the Policy Blotter to alert the office about interesting and relevant articles. Please send tips to

What’s new in Blotter news?

Former ASBMB President Jeremy Berg defines sustainable research funding in biomedical research.

Guest blog: Jeremy Berg talks sustainable research funding

In the journal Science, Berg wrote an editorial discussing the effects that steady growth of federal research funding will have on the biosciences community.

Benefits of steady growth

Funding for Zika research is running out. The lack of funding has led the science community to wonder why the U.S. Congress has failed to approve emergency funds.

Zika funding: What’s the holdup?


The House Committee on Energy and Commerce continues advocating for the 21st Century Cures Act. The committee thanked all those who have and will continue to take part in biomedical innovation.

Chairman Upton’s open letter to disease advocates (House of Energy and Commerce)


As the Obama administration enters its homestretch, the scientific community looks back on the president’s eight years in office and evaluates scientific progress made during that time. While bold initiatives to cure cancer, map the human brain and create personalized medicine were steps in the right direction, lack of increased funding for the National Institutes of Health may define the Obama administration’s influence on healthcare and biomedical research.   

Obama’s science legacy: betting big on biomedical science (Nature)


As diagnosed cases of domestically contracted Zika virus rise in the continental U.S., the director of the National Institute of Allergy and Infectious Disease, Anthony Fauci, warns of possible virus migration along the Gulf Coast, including parts of Texas and Louisiana. However, Fauci believes this will not turn into an “outbreak” scenario even though complete eradication of the disease will not be feasible for some time. Vaccine development remains at the forefront of Zika research but testing potential vaccines in humans poses unique issues. Progress in research continues, but Congress continues to deny emergency funding. The lack of approved emergency funds has the science community worried that vaccine development will be delayed. Recently, Democratic presidential nominee Hillary Clinton vowed that, if elected, she would set up a public-health emergency fund to prevent funding issues during future pandemics.

U.S. health official warns that Zika could spread to the Gulf Coast (CBC News)

NIH official: Don’t expect ‘broad’ Zika outbreak despite Florida cases (Washington Times)

Minimizing risk poses unique challenges in Zika vaccine trials, scientists say (Fox News)

Clinton sides with GOP on emergency health fund (The Hill)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.